Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Angel Oak Mortgage REIT | AOMR | Nov 15, 2024 | 9.80 | -0.61 |
Anghami | ANGH | Nov 15, 2024 | 0.74 | -2.62 |
Angi A | ANGI | Nov 15, 2024 | 1.72 | -1.71 |
AngioDynamics | ANGO | Nov 15, 2024 | 6.81 | -0.58 |
Anglogold Ashanti | AU | Nov 15, 2024 | 23.83 | -0.75 |
Anheuser-Busch InBev ADR | BUD | Nov 15, 2024 | 56.25 | -0.18 |
ANI Pharmaceuticals | ANIP | Nov 15, 2024 | 56.58 | -3.96 |
Anika Therapeutics | ANIK | Nov 15, 2024 | 17.25 | +1.47 |
Anixa Biosciences | ANIX | Nov 15, 2024 | 3.08 | -1.60 |
Annaly Capital Management | NLY | Nov 15, 2024 | 19.69 | +0.51 |
Annaly Capital Management F Pref | NLY-F | Nov 15, 2024 | 25.92 | -0.23 |
Annaly Capital Management G Pref | NLY-G | Nov 15, 2024 | 25.49 | -0.23 |
Annaly Capital Management I Pref | NLY-I | Nov 15, 2024 | 25.87 | -0.31 |
Annexon | ANNX | Nov 15, 2024 | 6.12 | -3.32 |
Annovis Bio | ANVS | Nov 15, 2024 | 6.84 | -1.87 |
ANSYS | ANSS | Nov 15, 2024 | 332.38 | -2.32 |
Antelope Enterprise | AEHL | Nov 15, 2024 | 0.31 | +1.87 |
Anterix | ATEX | Nov 15, 2024 | 33.61 | +5.26 |
Antero Midstream | AM | Nov 15, 2024 | 15.25 | +1.06 |
Antero Resources | AR | Nov 15, 2024 | 30.49 | +0.26 |
Anywhere Real Estate | HOUS | Nov 15, 2024 | 3.97 | +0.51 |
Aon | AON | Nov 15, 2024 | 379.29 | +0.79 |
APA | APA | Nov 15, 2024 | 22.38 | -0.97 |
Apartment Investment and Management | AIV | Nov 15, 2024 | 8.63 | +2.01 |
Apellis Pharmaceuticals | APLS | Nov 15, 2024 | 26.27 | -6.38 |
APi Group | APG | Nov 15, 2024 | 35.37 | -2.32 |
Apogee Enterprises | APOG | Nov 15, 2024 | 82.03 | -1.11 |
Apogee Therapeutics | APGE | Nov 15, 2024 | 47.25 | -7.36 |
Apollo Commercial Real Estate Finance | ARI | Nov 15, 2024 | 9.07 | -0.44 |
Apollo Global Management | APO | Nov 15, 2024 | 163.63 | -0.41 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.